Global Antimicrobial Susceptibility Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 123
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antimicrobial Susceptibility Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Antimicrobial Susceptibility Testing market. Further, it explains the major drivers and regional dynamics of the global Antimicrobial Susceptibility Testing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Biomérieux

- Danaher

- BD

- Thermo Fisher

- Bio-Rad

- Hi-Media

- Merlin

- Liofilchem

- Accelerate Diagnostics

- Alifax

- Creative Diagnostics

- Merck Group

- Synbiosis

- Bioanalyse

- Zhuhai Dl Biotech

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Antimicrobial Susceptibility Testing Segment by Type

- Antibacterial Susceptibility Testing

- Antifungal Susceptibility Testing

- Antiparasitic Susceptibility Testing

- Other Susceptibility Testing

Antimicrobial Susceptibility Testing Segment by Application

- Clinical Diagnostics

- Drug Discovery and Development

- Epidemiology

- Other Applications

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antimicrobial Susceptibility Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Antimicrobial Susceptibility Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Antimicrobial Susceptibility Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antimicrobial Susceptibility Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antimicrobial Susceptibility Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Antimicrobial Susceptibility Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Antimicrobial Susceptibility Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Biomérieux, Danaher, BD, Thermo Fisher, Bio-Rad, Hi-Media, Merlin, Liofilchem and Accelerate Diagnostics, etc.

Global Antimicrobial Susceptibility Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antimicrobial Susceptibility Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antibacterial Susceptibility Testing
1.2.3 Antifungal Susceptibility Testing
1.2.4 Antiparasitic Susceptibility Testing
1.2.5 Other Susceptibility Testing
1.3 Market by Application
1.3.1 Global Antimicrobial Susceptibility Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery and Development
1.3.4 Epidemiology
1.3.5 Other Applications
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Antimicrobial Susceptibility Testing Market Size (2017-2028)
2.2 Antimicrobial Susceptibility Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Antimicrobial Susceptibility Testing Market Size by Region (2017-2022)
2.4 Global Antimicrobial Susceptibility Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Antimicrobial Susceptibility Testing Countries Ranking by Market Size
3 Antimicrobial Susceptibility Testing Competitive by Company
3.1 Global Antimicrobial Susceptibility Testing Revenue by Players
3.1.1 Global Antimicrobial Susceptibility Testing Revenue by Players (2017-2022)
3.1.2 Global Antimicrobial Susceptibility Testing Market Share by Players (2017-2022)
3.2 Global Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Antimicrobial Susceptibility Testing Revenue
3.4 Global Antimicrobial Susceptibility Testing Market Concentration Ratio
3.4.1 Global Antimicrobial Susceptibility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antimicrobial Susceptibility Testing Revenue in 2021
3.5 Global Antimicrobial Susceptibility Testing Key Players Head office and Area Served
3.6 Key Players Antimicrobial Susceptibility Testing Product Solution and Service
3.7 Date of Enter into Antimicrobial Susceptibility Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Antimicrobial Susceptibility Testing Breakdown Data by Type
4.1 Global Antimicrobial Susceptibility Testing Historic Revenue by Type (2017-2022)
4.2 Global Antimicrobial Susceptibility Testing Forecasted Revenue by Type (2023-2028)
5 Global Antimicrobial Susceptibility Testing Breakdown Data by Application
5.1 Global Antimicrobial Susceptibility Testing Historic Market Size by Application (2017-2022)
5.2 Global Antimicrobial Susceptibility Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antimicrobial Susceptibility Testing Revenue by Company (2020-2022)
6.2 North America Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
6.3 North America Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
6.4 North America Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Antimicrobial Susceptibility Testing Revenue by Company (2020-2022)
7.2 Europe Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
7.3 Europe Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
7.4 Europe Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Antimicrobial Susceptibility Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Antimicrobial Susceptibility Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Antimicrobial Susceptibility Testing Revenue by Company (2020-2022)
9.2 Latin America Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
9.3 Latin America Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
9.4 Latin America Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Biomérieux
11.1.1 Biomérieux Company Details
11.1.2 Biomérieux Business Overview
11.1.3 Biomérieux Antimicrobial Susceptibility Testing Products and Services
11.1.4 Biomérieux Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.1.5 Biomérieux Antimicrobial Susceptibility Testing SWOT Analysis
11.1.6 Biomérieux Recent Developments
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Antimicrobial Susceptibility Testing Products and Services
11.2.4 Danaher Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.2.5 Danaher Antimicrobial Susceptibility Testing SWOT Analysis
11.2.6 Danaher Recent Developments
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Antimicrobial Susceptibility Testing Products and Services
11.3.4 BD Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.3.5 BD Antimicrobial Susceptibility Testing SWOT Analysis
11.3.6 BD Recent Developments
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Details
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Products and Services
11.4.4 Thermo Fisher Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.4.5 Thermo Fisher Antimicrobial Susceptibility Testing SWOT Analysis
11.4.6 Thermo Fisher Recent Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Antimicrobial Susceptibility Testing Products and Services
11.5.4 Bio-Rad Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.5.5 Bio-Rad Antimicrobial Susceptibility Testing SWOT Analysis
11.5.6 Bio-Rad Recent Developments
11.6 Hi-Media
11.6.1 Hi-Media Company Details
11.6.2 Hi-Media Business Overview
11.6.3 Hi-Media Antimicrobial Susceptibility Testing Products and Services
11.6.4 Hi-Media Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.6.5 Hi-Media Antimicrobial Susceptibility Testing SWOT Analysis
11.6.6 Hi-Media Recent Developments
11.7 Merlin
11.7.1 Merlin Company Details
11.7.2 Merlin Business Overview
11.7.3 Merlin Antimicrobial Susceptibility Testing Products and Services
11.7.4 Merlin Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.7.5 Merlin Antimicrobial Susceptibility Testing SWOT Analysis
11.7.6 Merlin Recent Developments
11.8 Liofilchem
11.8.1 Liofilchem Company Details
11.8.2 Liofilchem Business Overview
11.8.3 Liofilchem Antimicrobial Susceptibility Testing Products and Services
11.8.4 Liofilchem Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.8.5 Liofilchem Antimicrobial Susceptibility Testing SWOT Analysis
11.8.6 Liofilchem Recent Developments
11.9 Accelerate Diagnostics
11.9.1 Accelerate Diagnostics Company Details
11.9.2 Accelerate Diagnostics Business Overview
11.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Products and Services
11.9.4 Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.9.5 Accelerate Diagnostics Antimicrobial Susceptibility Testing SWOT Analysis
11.9.6 Accelerate Diagnostics Recent Developments
11.10 Alifax
11.10.1 Alifax Company Details
11.10.2 Alifax Business Overview
11.10.3 Alifax Antimicrobial Susceptibility Testing Products and Services
11.10.4 Alifax Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.10.5 Alifax Antimicrobial Susceptibility Testing SWOT Analysis
11.10.6 Alifax Recent Developments
11.11 Creative Diagnostics
11.11.1 Creative Diagnostics Company Details
11.11.2 Creative Diagnostics Business Overview
11.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Products and Services
11.11.4 Creative Diagnostics Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.11.5 Creative Diagnostics Recent Developments
11.12 Merck Group
11.12.1 Merck Group Company Details
11.12.2 Merck Group Business Overview
11.12.3 Merck Group Antimicrobial Susceptibility Testing Products and Services
11.12.4 Merck Group Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.12.5 Merck Group Recent Developments
11.13 Synbiosis
11.13.1 Synbiosis Company Details
11.13.2 Synbiosis Business Overview
11.13.3 Synbiosis Antimicrobial Susceptibility Testing Products and Services
11.13.4 Synbiosis Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.13.5 Synbiosis Recent Developments
11.14 Bioanalyse
11.14.1 Bioanalyse Company Details
11.14.2 Bioanalyse Business Overview
11.14.3 Bioanalyse Antimicrobial Susceptibility Testing Products and Services
11.14.4 Bioanalyse Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.14.5 Bioanalyse Recent Developments
11.15 Zhuhai Dl Biotech
11.15.1 Zhuhai Dl Biotech Company Details
11.15.2 Zhuhai Dl Biotech Business Overview
11.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Products and Services
11.15.4 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022)
11.15.5 Zhuhai Dl Biotech Recent Developments
12 Antimicrobial Susceptibility Testing Market Dynamics
12.1 Antimicrobial Susceptibility Testing Market Trends
12.2 Antimicrobial Susceptibility Testing Market Drivers
12.3 Antimicrobial Susceptibility Testing Market Challenges
12.4 Antimicrobial Susceptibility Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Antimicrobial Susceptibility Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antibacterial Susceptibility Testing
Table 3. Key Players of Antifungal Susceptibility Testing
Table 4. Key Players of Antiparasitic Susceptibility Testing
Table 5. Key Players of Other Susceptibility Testing
Table 6. Global Antimicrobial Susceptibility Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Antimicrobial Susceptibility Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Antimicrobial Susceptibility Testing Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Antimicrobial Susceptibility Testing Revenue Market Share by Region (2017-2022)
Table 10. Global Antimicrobial Susceptibility Testing Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Antimicrobial Susceptibility Testing Market Share by Players (2017-2022)
Table 12. Global Top Antimicrobial Susceptibility Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2021)
Table 13. Ranking of Global Top Antimicrobial Susceptibility Testing Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Antimicrobial Susceptibility Testing Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Antimicrobial Susceptibility Testing Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Antimicrobial Susceptibility Testing Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Antimicrobial Susceptibility Testing Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2022)
Table 21. Global Antimicrobial Susceptibility Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Antimicrobial Susceptibility Testing Revenue Market Share by Type (2023-2028)
Table 23. Global Antimicrobial Susceptibility Testing Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2022)
Table 25. Global Antimicrobial Susceptibility Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Antimicrobial Susceptibility Testing Revenue Market Share by Application (2023-2028)
Table 27. North America Antimicrobial Susceptibility Testing Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Antimicrobial Susceptibility Testing Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Antimicrobial Susceptibility Testing Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Antimicrobial Susceptibility Testing Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Antimicrobial Susceptibility Testing Revenue by Country (2023-2028) & (US$ Million)
Table 62. Biomérieux Company Details
Table 63. Biomérieux Business Overview
Table 64. Biomérieux Antimicrobial Susceptibility Testing Product and Services
Table 65. Biomérieux Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 66. Biomérieux Antimicrobial Susceptibility Testing SWOT Analysis
Table 67. Biomérieux Recent Developments
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher Antimicrobial Susceptibility Testing Product and Services
Table 71. Danaher Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 72. Danaher Antimicrobial Susceptibility Testing SWOT Analysis
Table 73. Danaher Recent Developments
Table 74. BD Company Details
Table 75. BD Business Overview
Table 76. BD Antimicrobial Susceptibility Testing Product and Services
Table 77. BD Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 78. BD Antimicrobial Susceptibility Testing SWOT Analysis
Table 79. BD Recent Developments
Table 80. Thermo Fisher Company Details
Table 81. Thermo Fisher Business Overview
Table 82. Thermo Fisher Antimicrobial Susceptibility Testing Product and Services
Table 83. Thermo Fisher Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 84. Thermo Fisher Antimicrobial Susceptibility Testing SWOT Analysis
Table 85. Thermo Fisher Recent Developments
Table 86. Bio-Rad Company Details
Table 87. Bio-Rad Business Overview
Table 88. Bio-Rad Antimicrobial Susceptibility Testing Product and Services
Table 89. Bio-Rad Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 90. Bio-Rad Antimicrobial Susceptibility Testing SWOT Analysis
Table 91. Bio-Rad Recent Developments
Table 92. Hi-Media Company Details
Table 93. Hi-Media Business Overview
Table 94. Hi-Media Antimicrobial Susceptibility Testing Product and Services
Table 95. Hi-Media Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 96. Hi-Media Antimicrobial Susceptibility Testing SWOT Analysis
Table 97. Hi-Media Recent Developments
Table 98. Merlin Company Details
Table 99. Merlin Business Overview
Table 100. Merlin Antimicrobial Susceptibility Testing Product and Services
Table 101. Merlin Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 102. Merlin Antimicrobial Susceptibility Testing SWOT Analysis
Table 103. Merlin Recent Developments
Table 104. Liofilchem Company Details
Table 105. Liofilchem Business Overview
Table 106. Liofilchem Antimicrobial Susceptibility Testing Product and Services
Table 107. Liofilchem Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 108. Liofilchem Antimicrobial Susceptibility Testing SWOT Analysis
Table 109. Liofilchem Recent Developments
Table 110. Accelerate Diagnostics Company Details
Table 111. Accelerate Diagnostics Business Overview
Table 112. Accelerate Diagnostics Antimicrobial Susceptibility Testing Product and Services
Table 113. Accelerate Diagnostics Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 114. Accelerate Diagnostics Antimicrobial Susceptibility Testing SWOT Analysis
Table 115. Accelerate Diagnostics Recent Developments
Table 116. Alifax Company Details
Table 117. Alifax Business Overview
Table 118. Alifax Antimicrobial Susceptibility Testing Product and Services
Table 119. Alifax Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 120. Alifax Antimicrobial Susceptibility Testing SWOT Analysis
Table 121. Alifax Recent Developments
Table 122. Creative Diagnostics Company Details
Table 123. Creative Diagnostics Business Overview
Table 124. Creative Diagnostics Antimicrobial Susceptibility Testing Product and Services
Table 125. Creative Diagnostics Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 126. Creative Diagnostics Recent Developments
Table 127. Merck Group Company Details
Table 128. Merck Group Business Overview
Table 129. Merck Group Antimicrobial Susceptibility Testing Product and Services
Table 130. Merck Group Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 131. Merck Group Recent Developments
Table 132. Synbiosis Company Details
Table 133. Synbiosis Business Overview
Table 134. Synbiosis Antimicrobial Susceptibility Testing Product and Services
Table 135. Synbiosis Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 136. Synbiosis Recent Developments
Table 137. Bioanalyse Company Details
Table 138. Bioanalyse Business Overview
Table 139. Bioanalyse Antimicrobial Susceptibility Testing Product and Services
Table 140. Bioanalyse Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 141. Bioanalyse Recent Developments
Table 142. Zhuhai Dl Biotech Company Details
Table 143. Zhuhai Dl Biotech Business Overview
Table 144. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Product and Services
Table 145. Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Revenue in Antimicrobial Susceptibility Testing Business (2017-2022) & (US$ Million)
Table 146. Zhuhai Dl Biotech Recent Developments
Table 147. Antimicrobial Susceptibility Testing Market Trends
Table 148. Antimicrobial Susceptibility Testing Market Drivers
Table 149. Antimicrobial Susceptibility Testing Market Challenges
Table 150. Antimicrobial Susceptibility Testing Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antimicrobial Susceptibility Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Antibacterial Susceptibility Testing Features
Figure 3. Antifungal Susceptibility Testing Features
Figure 4. Antiparasitic Susceptibility Testing Features
Figure 5. Other Susceptibility Testing Features
Figure 6. Global Antimicrobial Susceptibility Testing Sales Market Share by Application: 2021 VS 2028
Figure 7. Clinical Diagnostics Case Studies
Figure 8. Drug Discovery and Development Case Studies
Figure 9. Epidemiology Case Studies
Figure 10. Other Applications Case Studies
Figure 11. Antimicrobial Susceptibility Testing Report Years Considered
Figure 12. Global Antimicrobial Susceptibility Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antimicrobial Susceptibility Testing Market Size 2017-2028 (US$ Million)
Figure 14. Global Antimicrobial Susceptibility Testing Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Antimicrobial Susceptibility Testing Revenue Market Share by Region in 2017 VS 2022
Figure 16. Global Top 10 Antimicrobial Susceptibility Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 17. Global Antimicrobial Susceptibility Testing Market Share by Players in 2021
Figure 18. Global Top Antimicrobial Susceptibility Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Susceptibility Testing as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Antimicrobial Susceptibility Testing Revenue in 2021
Figure 20. North America Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2021
Figure 21. North America Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2028)
Figure 22. North America Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2028)
Figure 23. North America Antimicrobial Susceptibility Testing Revenue Share by Country (2017-2028)
Figure 24. U.S. Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 25. Canada Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 26. Europe Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2021
Figure 27. Europe Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2028)
Figure 28. Europe Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2028)
Figure 29. Europe Antimicrobial Susceptibility Testing Revenue Share by Country (2017-2028)
Figure 30. Germany Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 31. France Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 32. U.K. Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 33. Italy Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 34. Russia Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2021
Figure 36. Asia Pacific Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2028)
Figure 37. Asia Pacific Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2028)
Figure 38. Asia Pacific Antimicrobial Susceptibility Testing Revenue Share by Region (2017-2028)
Figure 39. China Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 40. Japan Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 41. South Korea Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 42. India Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 43. Australia Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 44. China Taiwan Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Indonesia Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Thailand Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Malaysia Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2021
Figure 49. Latin America Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Antimicrobial Susceptibility Testing Revenue Share by Country (2017-2028)
Figure 52. Mexico Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Antimicrobial Susceptibility Testing Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Antimicrobial Susceptibility Testing Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Antimicrobial Susceptibility Testing Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Antimicrobial Susceptibility Testing Revenue Share by Country (2017-2028)
Figure 59. Turkey Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Antimicrobial Susceptibility Testing Revenue (2017-2028) & (US$ Million)
Figure 62. Biomérieux Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 63. Danaher Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 64. BD Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 65. Thermo Fisher Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 66. Bio-Rad Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 67. Hi-Media Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 68. Merlin Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 69. Liofilchem Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 70. Accelerate Diagnostics Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 71. Alifax Revenue Growth Rate in Antimicrobial Susceptibility Testing Business (2017-2022)
Figure 72. Creative Diagnostics Revenue Growth
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs